Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank86
3Y CAGR+40.7%
5Y CAGR+59.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+40.7%/yr
vs +202.1%/yr prior
5Y CAGR
+59.4%/yr
Recent deceleration
Acceleration
-161.4pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
10.3x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$279.72M-3.8%
2024$290.66M+146.5%
2023$117.93M+17.5%
2022$100.38M+61.3%
2021$62.22M+128.6%
2020$27.22M+291.9%
2019$6.94M+476.3%
2018$1.21M-